Immunophenotype Expression Change From CD52+ to CD52- on Erythrodermic Peripheral T-cell Lymphoma, Not Otherwise Specified After Treatment With Alemtuzumab
Related Experiment Video
Updated: Jul 23, 2026

12:16
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
15.6K
Maulik M Dhandha1, Kari E Sufficool, Claudia I Vidal
1Department of Dermatology, Saint Louis University, St. Louis, MO.
The American Journal of Dermatopathology
|September 23, 2017
Abstract
No abstract available in PubMed .

